Erdafitinib (JNJ-42756493) CAS:1346242-81-6
Erdafitinib (JNJ-42756493)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1984 | 100mg | 225.00 | + Add to cart |
|
| R-C-1984 | 200mg | 400.00 | + Add to cart |
|
| R-C-1984 | 500mg | 800.00 | + Add to cart |
|
|
|
||||
Product description
Erdafitinib(JNJ-42756493)is a potent and selective orally bioavailable,pan fibroblast growth factor receptor(FGFR)inhibitor with potential antineoplastic activity.JNJ-42756493 binds to and inhibits FGFR,which may result in the inhibition of FGFR-related signal transduction pathways and thus the inhibition of tumor cell proliferation and tumor cell death in FGFR-overexpressing tumor cells.FGFR,upregulated in many tumor cell types,is a receptor tyrosine kinase essential to tumor cell proliferation, differentiation and survival.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---Erdafitinib (JNJ-42756493)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


